| 02.10.21 | Lilly antibody duo scores FDA nod; Face-mask fit matters, CDC says

Laden...

3 jaren geleden

Html
Tekst

Relief package targets vaccines, testing To view this email as a web page, click here

Webinar: The Benefits of Pharmacist-Led Clinical Trials

Tuesday, February 23, 2021 | 1pm ET / 10am PT

This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now.

Today's Rundown

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear CDC director: Data show the fit of masks impacts their effectiveness House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments BioNTech gets rolling with mRNA production at former Novartis site in Marburg Here's a look at just how much COVID-19 hospitalizations cost COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

Featured Story

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

By Eric Sagonowsky

Two weeks after Eli Lilly unveiled data showing its COVID-19 combo of bamlanivimab and etesevimab slashed the risk of death and hospitalization for high-risk patients, the antibody cocktail has won its emergency FDA authorization. The nod squares Lilly up to Regeneron, which till now had the only authorized dual-antibody coronavirus cocktail.

Roundtable: Disruption, Acceleration & Innovation: Pharmacists on the Frontline

Thursday, March 4 | 12pm ET / 9am PT

This year, pharmacists will play a critical role in the United States’ COVID-19 immunization efforts. In this panel, experts will explore how pharmacists can leverage technology to automate administrative tasks and satisfy patient needs. Register to learn more.

CDC director: Data show the fit of masks impacts their effectiveness

By Tina Reed

Speaking at a White House briefing on the COVID-19 pandemic on Wednesday, CDC Director Rochelle Walensky, M.D., urged Americans not to grow complacent as she pointed to new data about the effectiveness of masks.

House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments

By Robert King

The House Energy & Commerce Committee unveiled its part of a $1.9 trillion COVID-19 relief package that includes funding for vaccines and testing as well as enticing states to expand Medicaid.

BioNTech gets rolling with mRNA production at former Novartis site in Marburg

By Eric Sagonowsky

BioNTech, under pressure with its COVID-19 vaccine partner Pfizer to manufacture as many doses as possible this year, has started production at a site in Germany it acquired from Novartis. The site will be able to turn out up to 750 million doses annually once it's fully online.

Here's a look at just how much COVID-19 hospitalizations cost

By Paige Minemyer

New data from the Blue Cross and Blue Shield Association take a look at just how much COVID-19 cases are costing insurers.

COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost

By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale

WHO recommended AstraZeneca's vaccine for all adults ages 18 and up. AstraZeneca aims to accelerate finished vaccine output in Europe, and Korea approved AZ's shot for emergency use. Plus, some patients developed a rare blood disorder after getting Pfizer or Moderna's shots, though a direct link hasn't been confirmed.

UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

Whitepaper: Accelerating Cloud-Connected Epic Workloads

Now, more than ever, healthcare needs to speed up data-driven response time. The faster a healthcare provider can access the information they need, the quicker they can provide safer patient care diagnosis and treatment. Download this whitepaper to learn more.

Deel deze op

Laden...

Andere nieuwsbrieven van Fiercebiotech.com

Meer nieuwsbrieven van Fiercebiotech.com

Laden...

COVID-19 Tracker

Featured Story

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Top Stories

CDC director: Data show the fit of masks impacts their effectiveness

House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments

BioNTech gets rolling with mRNA production at former Novartis site in Marburg

Here's a look at just how much COVID-19 hospitalizations cost

COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost

UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

| 02.10.21 | Lilly antibody duo scores FDA nod; Face-mask fit matters, CDC says

COVID-19 Tracker

Featured Story

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Top Stories

CDC director: Data show the fit of masks impacts their effectiveness

House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments

BioNTech gets rolling with mRNA production at former Novartis site in Marburg

Here's a look at just how much COVID-19 hospitalizations cost

COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost

UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

Deel deze op

Andere nieuwsbrieven van Fiercebiotech.com

Gerelateerde nieuwsbrieven